|
National Women's Health Week
|
|
|
National Women's Health Week Clinical Trials
- Women's Health Research Registry
ClinicalTrials.gov Identifier: NCT00574314 - Recruiting
Healthy
- Weekly vs. Every 2 Week vs. Every 3 Week Administration of Abraxane/Bevacizumab Combination in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00281528 - Recruiting
Breast Neoplasms; Neoplasm Metastasis
- A 12-Week Study of Pramipexole ER in Patients With Parkinson?s Disease, Followed by a 52-Week Long-Term Treatment Period
ClinicalTrials.gov Identifier: NCT00560508 - Recruiting
Parkinson Disease
- The Symptom Experience of Women With Perimenstrual Syndrome;Women's Health Related Quality of Life.
ClinicalTrials.gov Identifier: NCT00174161 - Recruiting
Premenstrual Syndrome
- A Comparison of Differin Gel, 0.1% vs. Tazorac Cream, 0.1% vs. Differin Gel, 0.1% 6-Week Treatment Switched to Tazorac Cream, 0.1% 6-Week Treatment in Patients With Acne Vulgaris
ClinicalTrials.gov Identifier: NCT00469755 - Active, not recruiting
Facial Acne Vulgaris.
- The Effect of the Mini-Pill on Blood Factors in Women at Increased Risk for Forming Blood Clots
ClinicalTrials.gov Identifier: NCT00580424 - Recruiting
Women's Health; Blood Coagulation Disorders
- Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study
ClinicalTrials.gov Identifier: NCT00341159 - Active, not recruiting
Breast Cancer
- Influence of Social and Environmental Factors on Women's Reproductive Function in a Maya Community of Guatemala
ClinicalTrials.gov Identifier: NCT00340782 - Active, not recruiting
Early Pregnancy
- Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
ClinicalTrials.gov Identifier: NCT00309244 - Recruiting
Diabetes Mellitus, Type 2
- Women's Initiative for Pelvic Pain and Sexual Health (WISH) Program in the Department of Urology at Beaumont
ClinicalTrials.gov Identifier: NCT00379002 - Recruiting
Interstitial Cystitis; Sexual Dysfunction; Pelvic Pain
- Acupuncture for Women's Health Conditions
ClinicalTrials.gov Identifier: NCT00090389 - Active, not recruiting
Ovarian Neoplasms; Endometriosis; Pelvic Pain; Uterine Neoplasms
- ORWH:SCOR - Sex/Gender Factors Affecting Women's Health
ClinicalTrials.gov Identifier: NCT00068120 - Recruiting
Urinary Tract Infection
- Study Assessing the Effect of 3-Week Treatment With One of Three Oral Doses of Quinagolide
ClinicalTrials.gov Identifier: NCT00329693 - Active, not recruiting
Ovarian Hyperstimulation Syndrome
- Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury
ClinicalTrials.gov Identifier: NCT00148239 - Active, not recruiting
Spinal Cord Injuries
- Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week
ClinicalTrials.gov Identifier: NCT00537888 - Active, not recruiting
Pulmonary Candidiasis
- A Six-Week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in COPD
ClinicalTrials.gov Identifier: NCT00239421 - Active, not recruiting
Pulmonary Disease, Chronic Obstructive
- A Two-Week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects
ClinicalTrials.gov Identifier: NCT00449527 - Active, not recruiting
Asthma
- A 24-52-Week Study to Evaluate the Long-Term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)
ClinicalTrials.gov Identifier: NCT00336713 - Active, not recruiting
Depressive Disorder
- A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS
ClinicalTrials.gov Identifier: NCT00375284 - Active, not recruiting
Restless Legs Syndrome
- A North-American Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder
ClinicalTrials.gov Identifier: NCT00390650 - Active, not recruiting
Anxiety
- A 24-Week up-Titration Trial of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
ClinicalTrials.gov Identifier: NCT00360555 - Active, not recruiting
Sexual Dysfunctions, Psychological
- A Two-Week Study Assessing the Onset of Effect Questionnaire Administered Pre-Dose Versus Post-Dose in Adult Subjects
ClinicalTrials.gov Identifier: NCT00449501 - Active, not recruiting
Asthma
- 24-Week Placebo-Controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
ClinicalTrials.gov Identifier: NCT00360529 - Active, not recruiting
Sexual Dysfunctions, Psychological
- A 24-Week Fixed Dose Trial of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
ClinicalTrials.gov Identifier: NCT00360243 - Active, not recruiting
Sexual Dysfunctions, Psychological
- Trial of Aspirin and Vitamin E in Women (Women's Health Study - WHS)
ClinicalTrials.gov Identifier: NCT00000479 - Active, not recruiting
Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Heart Diseases; Myocardial Infarction; Myocardial Ischemia; Vascular Diseases
- Tai Chi Mind-Body Therapy for Chronic Heart Failure
ClinicalTrials.gov Identifier: NCT00110227 - Recruiting
Heart Failure
- A 12 Week Study to Assess the Effectiveness of an Investigational Cholesterol-Lowering Drug in Patients That Have Been Hospitalized for a Possible Heart Problem
ClinicalTrials.gov Identifier: NCT00132717 - Active, not recruiting
Hypercholesterolemia
- The Women's Healthy Lifestyle Study
ClinicalTrials.gov Identifier: NCT00583726 - Recruiting
Breast Cancer
- An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder
ClinicalTrials.gov Identifier: NCT00358631 - Active, not recruiting
Depressive Disorder
- An Eight-Week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder
ClinicalTrials.gov Identifier: NCT00390533 - Active, not recruiting
Generalized Anxiety
- A 12-Week Safety and Pharmacodynamic Study of AT1001 in Female Patients With Fabry Disease
ClinicalTrials.gov Identifier: NCT00304512 - Active, not recruiting
Fabry Disease
- An Eight-Week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder
ClinicalTrials.gov Identifier: NCT00415142 - Active, not recruiting
Depressive Disorder
- A 24-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease
ClinicalTrials.gov Identifier: NCT00283933 - Active, not recruiting
Fabry Disease
- A 12-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease
ClinicalTrials.gov Identifier: NCT00283959 - Active, not recruiting
Fabry Disease
- Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144AM)
ClinicalTrials.gov Identifier: NCT00202839 - Active, not recruiting
Hepatitis C, Chronic
- Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma -A Long Term (24-Week) Study-
ClinicalTrials.gov Identifier: NCT00449046 - Active, not recruiting
Bronchial Asthma
- Colorado Women's Prison Project - 1
ClinicalTrials.gov Identifier: NCT00249561 - Recruiting
Substance-Related Disorders
- Women's Interagency HIV Study (WIHS)
ClinicalTrials.gov Identifier: NCT00000797 - Active, not recruiting
HIV Infections
- A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
ClinicalTrials.gov Identifier: NCT00171119 - Active, not recruiting
Hypertension; Diabetic Nephropathy
- Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis
ClinicalTrials.gov Identifier: NCT00436995 - Active, not recruiting
Chronic Kidney Disease
- A 6-Week Open Label Cross-Over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
ClinicalTrials.gov Identifier: NCT00209261 - Active, not recruiting
Primary Nocturnal Enuresis
- A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
ClinicalTrials.gov Identifier: NCT00171093 - Active, not recruiting
Hypertension; Hypercholesterolemia
- 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
ClinicalTrials.gov Identifier: NCT00069511 - Active, not recruiting
Hepatitis C
- A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00170937 - Active, not recruiting
Metabolic Syndrome; Hypertension; Pre-Hypertension
- Women's Treatment for Trauma and Substance Use Disorders - 1
ClinicalTrials.gov Identifier: NCT00078156 - Active, not recruiting
Substance-Related Disorders
- Can Acupuncture Be Used as Preparation for Induction of Labour
ClinicalTrials.gov Identifier: NCT00245752 - Recruiting
Pregnancy Overdue - Week 41+6
- A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee.
ClinicalTrials.gov Identifier: NCT00483977 - Recruiting
Osteoarthritis
- Risedronate Sodium on Bone in Postmenopausal Women with Hormone-Receptor-Positive Early Breast Cancer
ClinicalTrials.gov Identifier: NCT00082277 - Active, not recruiting
Breast Cancer
- A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 HFA Versus Fluticasone Propionate 100 HFA In Children With Asthma
ClinicalTrials.gov Identifier: NCT00441441 - Active, not recruiting
Asthma
- Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00120211 - Active, not recruiting
Head and Neck Cancer
- Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
ClinicalTrials.gov Identifier: NCT00426946 - Recruiting
Depression
- 52-Week Add-on to Metformin Comparison of Saxagliptin and Sulphonylurea
ClinicalTrials.gov Identifier: NCT00575588 - Recruiting
Type 2 Diabetes
- Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method
ClinicalTrials.gov Identifier: NCT00386360 - Recruiting
Osteopenia
- A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study
ClinicalTrials.gov Identifier: NCT00192608 - Active, not recruiting
HIV Infections
- 3-Week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
ClinicalTrials.gov Identifier: NCT00312494 - Recruiting
Bipolar Disorder
- Compare the Efficacy and Safety of 48-Week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
ClinicalTrials.gov Identifier: NCT00362635 - Recruiting
Hepatitis B
- A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With ORG 50081.
ClinicalTrials.gov Identifier: NCT00506389 - Recruiting
Insomnia; Quality of Life
- A Six-Week Randomized Trial of Lipitor(Atorvastatin) for the Treatment of PCOS Women With Elevated LDL Cholesterol
ClinicalTrials.gov Identifier: NCT00529542 - Recruiting
Polycystic Ovary Syndrome
- National Health and Nutrition Examination Survey IV (NHANES (IV)
ClinicalTrials.gov Identifier: NCT00005154 - Active, not recruiting
Cardiovascular Diseases; Coronary Disease; Heart Diseases; Hypertension; Blood Disease; Lung Diseases
- Women's Ischemia Syndrome Evaluation (WISE)
ClinicalTrials.gov Identifier: NCT00000554 - Active, not recruiting
Angina Pectoris; Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
- Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo
ClinicalTrials.gov Identifier: NCT00570063 - Recruiting
Schizophrenia
- Open-Label, 48 Week Extension Study of Elvucitabine in Combination With Background ART For Subjects Who Have Completed ACH443-014A
ClinicalTrials.gov Identifier: NCT00380159 - Recruiting
HIV-1 Infection
- EARLY 3-Months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA
ClinicalTrials.gov Identifier: NCT00562588 - Recruiting
Cerebrovascular Accident
- AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year
ClinicalTrials.gov Identifier: NCT00146913 - Active, not recruiting
Chronic Myeloid Leukemia
- 12- Week Open Label Treatment of Refractory Bipolar Depression
ClinicalTrials.gov Identifier: NCT00223496 - Recruiting
Bipolar Disorder
- Oral Health Education Program
ClinicalTrials.gov Identifier: NCT00103493 - Active, not recruiting
Dental Caries; Oral hygiene; Oral health; Dental health
- National Survey of Lead and Allergen Hazards in Housing
ClinicalTrials.gov Identifier: NCT00339573 - Active, not recruiting
Lead Toxicity; Environmental Allergens
- Young Women's Breast Cancer Research Program
ClinicalTrials.gov Identifier: NCT00276120 - Recruiting
Invasive Breast Cancer
- More Frequent Dialysis (>3 Treatments Per Week)
ClinicalTrials.gov Identifier: NCT00575497 - Recruiting
End Stage Renal Disease; Chronic Kidney Disease
- Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response
ClinicalTrials.gov Identifier: NCT00392002 - Active, not recruiting
Gastroesophageal Reflux
- An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder
ClinicalTrials.gov Identifier: NCT00374166 - Recruiting
Anxiety Disorders
- A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatiod Arthritis
ClinicalTrials.gov Identifier: NCT00550043 - Recruiting
Rheumatoid Arthritis
- 12-Week Open-Label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
ClinicalTrials.gov Identifier: NCT00525824 - Recruiting
Hypercholesterolemia; Coronary Heart Disease; Atherosclerosis
- A 48 week study looking at the effectiveness of giving saquinavir/ritonavir, twice daily plus emtricitabine/tenofovir, once daily compared to giving lopinavir/ritonavir twice daily plus emtricitabine/tenofovir once daily in HIV-1 patients not previously t
ClinicalTrials.gov Identifier: NCT00105079 - Active, not recruiting
HIV Infections
- Natural History Study of Patients With Central Nervous System Tumors Being Evaluated at the National Institutes of Health
ClinicalTrials.gov Identifier: NCT00458640 - Recruiting
Brain and Central Nervous System Tumors; Chordoma; Neuroblastoma
- Women's Antioxidant and Cardiovascular Study (WACS)
ClinicalTrials.gov Identifier: NCT00000541 - Active, not recruiting
Cardiovascular Diseases; Coronary Arteriosclerosis; Coronary Disease; Heart Diseases; Myocardial Infarction; Myocardial Ischemia
- The National Danish Schizophrenia Project
ClinicalTrials.gov Identifier: NCT00221585 - Active, not recruiting
Schizophrenia
- The Effectiveness of Health Advice and Occupational Health Intervention on Work Ability
ClinicalTrials.gov Identifier: NCT00378989 - Active, not recruiting
Signs and Symptoms
- School Intervention Study of Nutrition, Wellbeing and Dental Health
ClinicalTrials.gov Identifier: NCT00530153 - Active, not recruiting
Eating; Oral Health
- Late Effects of Radiation Therapy and Natural History of Disease in Patients Previously Treated for Cancer at the National Institutes of Health
ClinicalTrials.gov Identifier: NCT00436813 - Recruiting
Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
- A Six-Week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.
ClinicalTrials.gov Identifier: NCT00282464 - Recruiting
Bipolar I Depression
- An 8 Week Study to Evaluate Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00481195 - Recruiting
Bipolar I Depression
- An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder
ClinicalTrials.gov Identifier: NCT00417118 - Recruiting
Generalized Anxiety
- A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)
ClinicalTrials.gov Identifier: NCT00576108 - Recruiting
Postherpetic Neuralgia; Shingles; Herpes Zoster; Neuropathic Pain
- Showing Health Information Value in a Community Network
ClinicalTrials.gov Identifier: NCT00365885 - Active, not recruiting
Clinical Decision Support; Medical Informatics Interventions; Population Health Management; Quality of Healthcare
- Continuous Positive Airway Pressure (CPAP) Versus Surfactant, and a Lower Versus a Higher Oxygen Saturation in 24 to 27 Week Preterm Infants
ClinicalTrials.gov Identifier: NCT00233324 - Recruiting
Bronchopulmonary Dysplasia; Retinopathy of Prematurity
- A 15-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury
ClinicalTrials.gov Identifier: NCT00407745 - Recruiting
Neuralgia; Spinal Cord Injuries
- Testing the Right Question Project Health Education Strategy in a Mental Health Setting
ClinicalTrials.gov Identifier: NCT00134615 - Active, not recruiting
Depression; Anxiety; Other Psychiatric Disorder
- ORWH:SCOR on Sex and Gender Factors Affecting Women's Incontinence
ClinicalTrials.gov Identifier: NCT00069368 - Recruiting
Urinary Incontinence; Diabetes
- Open Label, 48 Week Study of the Ability of Lopinavir/Ritonavir to Influence the Immune Response in Patients Who Are on an HIV Suppressive Regimen But Have Demonstrated a Blunted Immune Recovery.
ClinicalTrials.gov Identifier: NCT00344487 - Recruiting
HIV
- A Cohort Study of Smoking Prevention and Health Promotion for Middle School Students in Wuhan, China
ClinicalTrials.gov Identifier: NCT00341653 - Active, not recruiting
Smoking; Respiratory Health
- A Phase II National, Open-Label, Multicenter, no Controled Study of Treated With Bortezomib (Velcade) Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning
ClinicalTrials.gov Identifier: NCT00564200 - Active, not recruiting
Multiple Myeloma
- Vitamins, Breastmilk HIV Shedding, and Child Health
ClinicalTrials.gov Identifier: NCT00197756 - Active, not recruiting
Maternal and Child Health Outcomes
- Mild Depression 2 Week Observational Study
ClinicalTrials.gov Identifier: NCT00285831 - Recruiting
Mild Depression (Dysthymia)
- A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis
ClinicalTrials.gov Identifier: NCT00403559 - Recruiting
Seborrheic Dermatitis
- A 12-Week Double-Blind, Placebo-Controlled, Multicenter Study with Varenicline Tartrate 1mg Bid for Smoking Cessation
ClinicalTrials.gov Identifier: NCT00155298 - Recruiting
Smoking
- Reducing Health Risk Behavior and Improving Health in Adolescents With Depression
ClinicalTrials.gov Identifier: NCT00461539 - Active, not recruiting
Depression
- Efficacy Trial of Gestational Sulfadoxine-Pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth
ClinicalTrials.gov Identifier: NCT00131235 - Active, not recruiting
Malaria in pregnancy; Sexually Transmitted Diseases; Preterm Birth
- A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00487058 - Recruiting
Advanced Solid Tumors
- 12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin
ClinicalTrials.gov Identifier: NCT00473525 - Recruiting
Diabetes Mellitus, Type 2
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
|